Los puntos clave no están disponibles para este artículo en este momento.
Abstract This chapter points out serious shortcomings in DEA's treatment of price efficiency, illustrates the dangers of misspecification errors in DEA, and suggests extentions of the basic DEA formulation that address these shortcomings.
Sexton et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: